The Skull as Therapeutic Infrastructure: How CraniUS and Chronic Convection Delivery Bypass the Blood-Brain Barrier
Dr. Dereck Mush, MD, MBA
What they do
The company manufactures the Omnipod system, a wearable, tubeless insulin pump that delivers continuous insulin. Endocrinology clinics and retail pharmacies distribute this device directly to patients with type 1 diabetes seeking an alternative to daily injections.
The record
- Vertical
- Medical Devices
- Sub-segment
- Drug delivery systems
- Product type
- Device
- Stage
- Public
- Headquarters
- Acton, USA
- Region
- North America
- Founded
- 2000
- Total funding
- $160M raised
Notable investors: Prism Venture Partners, Prospect Venture Partners.
Also in Medical Devices
Related on The Signal
Dr. Dereck Mush, MD, MBA
The Biophysical Tumor Barrier: Inside TriSalus's TriNav Advance Clearance and the Fluid Mechanics of Interventional Oncology
Dr. Dereck Mush, MD, MBA
Device and Drug as One Product: VOCERYQ, CELLECTRA and the Commercial Test for DNA Medicines
Dr. Dereck Mush, MD, MBA
Automated Insulin Delivery Just Got FDA Clearance for Type 2 Diabetes. What Changes for the Pump Market
Dr. Dereck Mush, MD, MBA